
| NAME | DATE | TM | OPP | MIN | PTS | REB | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  |  V. Wembanyama   | 10/22/2025    |  SAS | @    |  DAL | 30    | 40    | 15    | 1    | 1    | 3    | 15    | 21    | 71.4    | 1    | 2    | 50.0    | 9    | 11    | 81.8    | 77.4    | 1    | 14    | 0    | 4    | +31    | 
| 2 |  |  V. Wembanyama   | 10/24/2024    |  SAS | @    |  DAL | 28    | 17    | 9    | 1    | 0    | 1    | 5    | 18    | 27.8    | 1    | 8    | 12.5    | 6    | 6    | 100.0    | 41.2    | 2    | 7    | 4    | 1    | -20    | 
| 3 |  |  V. Wembanyama   | 3/19/2024    |  SAS | vs    |  DAL | 32    | 12    | 11    | 3    | 1    | 6    | 3    | 13    | 23.1    | 0    | 4    | 0.0    | 6    | 7    | 85.7    | 37.3    | 3    | 8    | 5    | 4    | +5    | 
| 4 |  |  V. Wembanyama   | 2/14/2024    |  SAS | @    |  DAL | 27    | 26    | 9    | 5    | 1    | 3    | 10    | 21    | 47.6    | 2    | 6    | 33.3    | 4    | 5    | 80.0    | 56.0    | 3    | 6    | 2    | 0    | -9    | 
| 5 |  |  V. Wembanyama   | 10/25/2023    |  SAS | vs    |  DAL | 23    | 15    | 5    | 2    | 2    | 1    | 6    | 9    | 66.7    | 3    | 5    | 60.0    | 0    | 1    | 0.0    | 79.4    | 0    | 5    | 5    | 5    | 0    | 
| 6 |  |  V. Oladipo   | 1/20/2023    |  MIA | @    |  DAL | 28    | 20    | 0    | 2    | 1    | 0    | 9    | 12    | 75.0    | 2    | 3    | 66.7    | 0    | 0    | 83.3    | 0    | 0    | 2    | 3    | -14    | |
| 7 |  |  V. Oladipo   | 3/8/2020    |  IND | @    |  DAL | 27    | 16    | 4    | 7    | 0    | 1    | 6    | 18    | 33.3    | 0    | 5    | 0.0    | 4    | 5    | 80.0    | 39.6    | 0    | 4    | 3    | 3    | +8    | 
| 8 |  |  V. Oladipo   | 2/3/2020    |  IND | vs    |  DAL | 23    | 9    | 0    | 2    | 0    | 1    | 4    | 17    | 23.5    | 1    | 10    | 10.0    | 0    | 0    | 26.5    | 0    | 0    | 0    | 2    | -11    | |
| 9 |  |  V. Oladipo   | 1/19/2019    |  IND | vs    |  DAL | 32    | 12    | 8    | 6    | 3    | 0    | 4    | 15    | 26.7    | 1    | 4    | 25.0    | 3    | 4    | 75.0    | 35.8    | 4    | 4    | 1    | 3    | +10    | 
| 10 |  |  V. Oladipo   | 2/26/2018    |  IND | @    |  DAL | 23    | 21    | 5    | 4    | 1    | 1    | 8    | 13    | 61.5    | 0    | 3    | 0.0    | 5    | 6    | 83.3    | 67.1    | 0    | 5    | 3    | 4    | +3    | 
| 11 |  |  V. Oladipo   | 3/27/2017    |  OKC | @    |  DAL | 37    | 15    | 10    | 2    | 1    | 1    | 6    | 15    | 40.0    | 3    | 6    | 50.0    | 0    | 0    | 50.0    | 1    | 9    | 2    | 3    | +12    | |
| 12 |  |  V. Oladipo   | 1/26/2017    |  OKC | vs    |  DAL | 36    | 17    | 3    | 3    | 3    | 0    | 7    | 14    | 50.0    | 1    | 4    | 25.0    | 2    | 2    | 100.0    | 57.1    | 0    | 3    | 2    | 2    | +10    | 
| 13 |  |  V. Oladipo   | 3/1/2016    |  ORL | @    |  DAL | 24    | 6    | 4    | 2    | 0    | 0    | 3    | 10    | 30.0    | 0    | 3    | 0.0    | 0    | 0    | 30.0    | 3    | 1    | 0    | 3    | -18    | |
| 14 |  |  V. Oladipo   | 2/19/2016    |  ORL | vs    |  DAL | 42    | 17    | 13    | 3    | 2    | 0    | 6    | 18    | 33.3    | 3    | 9    | 33.3    | 2    | 2    | 100.0    | 45.0    | 2    | 11    | 2    | 3    | +15    | 
| 15 |  |  V. Oladipo   | 3/18/2015    |  ORL | @    |  DAL | 37    | 19    | 4    | 6    | 2    | 1    | 7    | 20    | 35.0    | 0    | 6    | 0.0    | 5    | 6    | 83.3    | 42.0    | 0    | 4    | 5    | 4    | -9    | 
| 16 |  |  V. Oladipo   | 1/13/2014    |  ORL | @    |  DAL | 30    | 11    | 3    | 2    | 1    | 0    | 4    | 11    | 36.4    | 1    | 3    | 33.3    | 2    | 2    | 100.0    | 46.3    | 1    | 2    | 4    | 4    | -8    | 
| 17 |  |  V. Oladipo   | 11/16/2013    |  ORL | vs    |  DAL | 28    | 10    | 4    | 6    | 1    | 0    | 3    | 8    | 37.5    | 1    | 2    | 50.0    | 3    | 4    | 75.0    | 51.2    | 0    | 4    | 9    | 4    | -10    |